# US 2021/0277467 A1 · Safe sequencing system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277467 A1
- Document ID: US20210277467A1
- Status: Published application
- Kind: A1
- Application number: 17/324,253
- Filed: 2021-05-19
- Published: 2021-09-09
- Earliest claimed: 2011-04-15
- Assignees: The Johns Hopkins University
- Applicants: The Johns Hopkins University
- Inventors: Bert Vogelstein; Kenneth W. Kinzler; Nickolas Papadopoulos; Isaac A. Kinde
- Web page: https://patentgrep.com/patent/US20210277467A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 2525/179: incorporating arbitrary or random nucleotide sequences
- C12Q 2525/191: incorporating an adaptor
- C12Q 2563/179: the label being a nucleic acid
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The identification of mutations that are present in a small fraction of DNA templates is essential for progress in several areas of biomedical research. Though massively parallel sequencing instruments are in principle well-suited to this task, the error rates in such instruments are generally too high to allow confident identification of rare variants. We here describe an approach that can substantially increase the sensitivity of massively parallel sequencing instruments for this purpose. One example of this approach, called “Safe-SeqS” for (Safe-Sequencing System) includes (i) assignment of a unique identifier (UID) to each template molecule; (ii) amplification of each uniquely tagged template molecule to create UID-families; and (iii) redundant sequencing of the amplification products. PCR fragments with the same UID are truly mutant (“super-mutants”) if ≥95% of them contain the identical mutation. We illustrate the utility of this approach for determining the fidelity of a polymerase, the accuracy of oligonucleotides synthesized in vitro, and the prevalence of mutations in the nuclear and mitochondrial genomes of normal cells.

## Claims

### Claim 1

(canceled)

### Claim 2

A method for identifying a mutation in both strands of a double stranded DNA analyte molecule comprising:
a) attaching a unique identifier nucleic acid sequence (UID) to a first end of each strand of a double stranded DNA analyte molecule to form two uniquely identified analyte single-stranded DNA fragments;
b) amplifying both uniquely identified analyte single stranded DNA fragments to form two UID families each comprising a plurality of members;
c) redundantly sequencing said plurality of members from each of said two UID families, wherein said redundantly sequencing comprises generating sequencing reads from each of said plurality of members in each of said two UID families;
d) grouping said sequencing reads from each of said two UID families based on their UIDs; and
e) identifying a mutation in both strands of said double stranded DNA analyte molecule when greater than 95% of said sequencing reads from both of said two UID families share an identical mutation.

### Claim 3 (depends on 2)

The method of claim 2, wherein said nucleotide sequencing reads are at least 31 bases in length.

### Claim 4 (depends on 2)

The method of claim 2, wherein said nucleotide sequencing reads are at least 73 bases in length.

### Claim 5 (depends on 2)

The method of claim 2, wherein said nucleotide sequencing reads are between 36 and 73 bases in length.

### Claim 6 (depends on 2)

The method of claim 2, wherein said at least 95% is at least 97%.

### Claim 7 (depends on 2)

The method of claim 2, wherein said plurality of members in each of said two UID families comprises at least 5 members.

### Claim 8 (depends on 2)

The method of claim 2, wherein said plurality of members in each of said two UID families comprises at least 10 members.

### Claim 9 (depends on 2)

The method of claim 2, wherein said attaching is performed by ligation.

### Claim 10 (depends on 2)

The method of claim 2, wherein said attaching is performed by polymerase chain reaction.

### Claim 11 (depends on 2)

The method of claim 2, wherein prior to said amplifying, the double stranded DNA analyte molecule is treated with bisulfite to convert unmethylated cytosine bases to uracil.
